New Guidelines On the Use of PARP Inhibitors Help Doctors & Women With Ovarian Cancer Make Smarter Decisions

Updated September 17th, 2020

New Guidelines On the Use of PARP Inhibitors Help Doctors & Women With Ovarian Cancer Make Smarter Decisions

Guidelines recommend PARP inhibitors for a wider group of women; this is based on recent studies that found these drugs improve survival rates.

NOW
PLAYING
Major Victory For CAR T-Cell Therapy in Multiple Myeloma: FDA Advisory Panel Support For Abecma and Carvykti Therapies Earlier in The Disease Course, Despite Safety Concerns
NOW
PLAYING
Elahere: A Drug for Hard-To-Treat Ovarian Cancer
NOW
PLAYING
Elahere - A New Treatment For Ovarian Cancer That Has Returned
NOW
PLAYING
Elahere Offers Hope In Platinum-Resistant Ovarian Cancer
NOW
PLAYING
Elahere Provides Hope When Traditional Chemotherapy Stops Working
NOW
PLAYING
"Exceptionally Challenging Time" For Bridget Wilson Sampras and Tennis Legend Pete Sampras-- Seen For The First Time Since Announcing Her Ovarian Cancer Diagnosis

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... ovarian cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.